Holdings of M28 Capital Management LP
· Original filing · Compare with another fund · Report an error
- Net assets
- -
- Positions
- 7 in 2 countries
- Top ten
- 100.0 % of the equity sleeve
- Filed on
- Mar 31, 2026
Portfolio shape
Positions
| Rank | Company | Shares | Value | Weight |
|---|---|---|---|---|
| 1 | Invivyd Inc | 9,248,250 | 12M $ | |
| 2 | TG Therapeutics Inc | 88,354 | 2.9M $ | |
| 3 | Arrowhead Pharmaceuticals Inc | 36,851 | 2.3M $ | |
| 4 | Fractyl Health Inc | 1,856,117 | 849.7K $ | |
| 5 | Rocket Pharmaceuticals Inc | 210,871 | 754.9K $ | |
| 6 | Silence Therapeutics PLC | 101,203 | 533.3K $ | |
| 7 | CURIS INC | 284,889 | 155.9K $ |
Sector breakdown
- Unattributed 100.0 %
Titelia classification, company by company. The unattributed share stays visible.
Currency breakdown
- USD 100.0 %
The quoted currency of each line, as declared.
Country breakdown
- United States 97.3 %
- United Kingdom 2.7 %
Shares computed on the equity sleeve.
| Rank | Country | Lines | Value | Share |
|---|---|---|---|---|
| 1 | United States | 6 | 19M $ | 97.27 % |
| 2 | United Kingdom | 1 | 533.3K $ | 2.73 % |
Cite this page
Titelia. "Holdings of M28 Capital Management LP". https://titelia.com/en/funds/US13F1807489